T2DM Oral Meds Review Flashcards

1
Q

what drug class is metformin?
what is MoA?

A

biguanide
decreases hepatic glucose production and intestinal glucose absorption. also increases glucose uptake by skeletal muscle and fat. also activates AMP-activated protein kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what overall effect does metformin have in the body?

A

reduces blood glucose, increases sensitivity to insulin, and reduces blood lipid levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is a main AE of metformin?

A

lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are advantages/disadvantages of metformin?

A

no weight gain and low risk of hypoglycemia

GI SEs and rare lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what are the three sulfonylureas?

A

glipizide
glimepiride
glyburide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is MoA of sulfonylureas?

A

stimulate pancreatic B-cell activity by binding and inhibiting ATP-dependent potassium channels causing calcium to move into the cell and increase insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what overall effect do sulfonylureas have?

A

reduce blood glucose and lower risk of hypoglycemia compared to insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are AEs of sulfonylureas?

A

hypoglycemia and weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are advantages/disadvantages of sulfonylureas?

A

rapid FPG reduction and low cost

weight gain and high risk of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the two TZDs?

A

pioglitazone
rosiglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MoA of TZDs?

A

improve target cell response to insulin, decrease hepatic glucose output, increase insulin-dependent glucose uptake in skeletal muscle and fat.
Bind and activate PPA receptors which regulates gene expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

AEs of TZDs?

A

altered liver function, harmful cardiac effects, edema, and weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are advantages of TZDs?

A

decrease amount of insulin needed
low risk of hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the 2 meglitinides?

A

repaglinide
nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MoA of meglitinides?

A

stimulate glucose-mediated insulin secretion and upregulates ATP-dependent K+ channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SEs of meglitinides?

A

hypogylcemia, diarrhea, weight gain

17
Q

what is the name of the a-glucosidase inhibitor?

A

acarbose

18
Q

MoA of acarbose?

A

inhibit pancreatic a-amylase and membrane bound a-glucosidase enzymes to delay glucose absorption

19
Q

acarbose is mainly used to treat?

A

elevated postprandial glucose

20
Q

what are the names of the DPP-4 inhibitors?

A

sitagliptin
saxagliptin
linagliptin

21
Q

MoA of DPP-4 Is?

A

inhibit peptide hormone metabolism by DPP-4 enzyme and ehance activity of GLP-1

22
Q

what are advantages of DPP-4 Is?

A

no weight gain and low risk of hypoglycemia

23
Q

MoA of GLP-1 R agonists?

A

stimulate release of insulin and inhibit the release of glucose from the liver

24
Q

what are advantages of GLP-1 agonists?

A

reduced CVD risk

25
Q

MoA of SGLT2 inhibitors?

A

reduces reabsorption of filtered glucose and lowers the renal threshold for glucose to increase excretion of glucose

26
Q

what are advantages of SGLT2 Is?

A

reduced CVD risk